Schedule 13G ownership disclosure

UNITY BIOTECHNOLOGY INC

Common Stock, par value $0.0001 per share · CUSIP: 91381U200

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • ARCH Venture Fund VII, L.P.

    Shares: 0 · Class: 0%

  • ARCH Venture Fund VIII Overage, L.P.

    Shares: 0 · Class: 0%

  • ARCH Venture Partners VII, L.P.

    Shares: 0 · Class: 0%

  • ARCH Venture Partners VII, LLC

    Shares: 0 · Class: 0%

  • ARCH Venture Partners VIII, LLC

    Shares: 0 · Class: 0%

  • Keith Crandell

    Shares: 0 · Class: 0%

  • Clinton Bybee

    Shares: 0 · Class: 0%

  • Robert Nelsen

    Shares: 0 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001012975-25-000775
Form type
SCHEDULE 13G/A
Filer
ARCH Venture Fund VII, L.P.
CIK
CIK 1402439
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub